Silvia Deaglio - Concepedia

Author

Silvia Deaglio

University of Turin ORCID

Also Known As

Deaglio, Silvia, S Deaglio, S. Deaglio, Silvia DEAGLIO, Silvia Deaglio

469

Publications

17.4K

Citations

H-Index

100

Concepts

All Affiliations

University of Turin Italian institute for Genomic Medicine Università degli Studi del Piemonte Orientale “Amedeo Avogadro”Istituti di Ricovero e Cura a Carattere Scientifico Università Cattolica del Sacro Cuore

About

Silvia Deaglio is an author at University of Turin specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	57	4.9K
2	Education	1	1	26
3	Natural Sciences	1	1	186
4	Public Health	1	1	65
5	Allergy	1	1	96

Silvia Deaglio

148

Publications

13.8K

Citations

H-Index

Page 1

	Year	Citations
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression Silvia Deaglio, Karen M. Dwyer, Wenda Gao, The Journal of Experimental Medicine	2007	2.3K
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia Davide Rossi, Silvia Rasi, Giulia Fabbri, Blood	2011	438
The coding genome of splenic marginal zone lymphoma: activation of <i>NOTCH2</i> and other pathways regulating marginal zone development Davide Rossi, Marco Fangazio, Alessio Bruscaggin, The Journal of Experimental Medicine Lymphocyte DevelopmentImmunologyPathologyB Cell DevelopmentMarginal Zone Development	2012	377
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness Davide Rossi, Alessio Bruscaggin, Valeria Spina, Blood	2011	367
Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. Silvia Deaglio, M. Morra, Roberto Mallone, PubMed Molecular ImmunologyMolecular PhysiologyCell Surface MoleculeImmunologyTumor Immunity	1998	355
Human CD38 (ADP-Ribosyl Cyclase) Is a Counter-Receptor of CD31, an Ig Superfamily Member Silvia Deaglio, Massimo Morra, Roberto Mallone, The Journal of Immunology Molecular ImmunologyLigand Cd31Molecular PhysiologyImmunologyTumor Immunity	1998	343
CD39 and control of cellular immune responses Karen M. Dwyer, Silvia Deaglio, Wenda Gao, Purinergic Signalling Adaptive Immune SystemImmunologyImmune RegulationImmunologic MechanismAntigen Processing	2007	287
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia Davide Rossi, Marco Fangazio, Silvia Rasi, Blood	2012	276
Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome Davide Rossi, Valeria Spina, Michaela Cerri, Clinical Cancer Research	2009	223
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia Davide Brusa, Sara Serra, Marta Coscia, Haematologica	2013	219

Page 1